Detailed information for compound 1747929

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 546.912 | Formula: C38H62N2
  • H donors: 2 H acceptors: 0 LogP: 12.35 Rotable bonds: 22
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCCCCCCc1ccc(cc1)CNCC1CCCC(C1)CNCc1ccc(cc1)CCCCCCCC
  • InChi: 1S/C38H62N2/c1-3-5-7-9-11-13-16-33-20-24-35(25-21-33)29-39-31-37-18-15-19-38(28-37)32-40-30-36-26-22-34(23-27-36)17-14-12-10-8-6-4-2/h20-27,37-40H,3-19,28-32H2,1-2H3
  • InChiKey: NVQPLKDETMDXAK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Brugia malayi beta-lactamase 0.082 0.1338 1
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Leishmania major hypothetical protein, conserved 0.082 0.1338 0.5
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.082 0.1338 1
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Echinococcus multilocularis beta LACTamase domain containing family member 0.082 0.1338 1
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Onchocerca volvulus 0.082 0.1338 1
Onchocerca volvulus 0.082 0.1338 1
Plasmodium vivax hypothetical protein, conserved 0.082 0.1338 0.5
Toxoplasma gondii ABC1 family protein 0.082 0.1338 0.341
Brugia malayi beta-lactamase family protein 0.082 0.1338 1
Trichomonas vaginalis esterase, putative 0.082 0.1338 0.5
Onchocerca volvulus 0.082 0.1338 1
Mycobacterium tuberculosis Probable conserved lipoprotein LpqF 0.1323 0.2324 0.1138
Trichomonas vaginalis penicillin-binding protein, putative 0.082 0.1338 0.5
Toxoplasma gondii PAN domain-containing protein 0.214 0.3923 1
Mycobacterium ulcerans lipoprotein LpqF 0.1323 0.2324 0.2598
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.082 0.1338 1
Mycobacterium ulcerans class a beta-lactamase, BlaC 0.2757 0.5133 1
Trypanosoma brucei beta lactamase 0.1323 0.2324 1
Trypanosoma cruzi hypothetical protein, conserved 0.082 0.1338 0.5
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Loa Loa (eye worm) beta-lactamase 0.082 0.1338 1
Trichomonas vaginalis D-aminoacylase, putative 0.082 0.1338 0.5
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.082 0.1338 1
Mycobacterium tuberculosis Class a beta-lactamase BlaC 0.2757 0.5133 0.4382
Echinococcus granulosus beta LACTamase domain containing family member 0.082 0.1338 1
Toxoplasma gondii PAN domain-containing protein 0.214 0.3923 1
Trichomonas vaginalis D-aminoacylase, putative 0.082 0.1338 0.5
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Loa Loa (eye worm) hypothetical protein 0.082 0.1338 1
Trypanosoma cruzi hypothetical protein, conserved 0.082 0.1338 0.5
Trichomonas vaginalis D-aminoacylase, putative 0.082 0.1338 0.5
Mycobacterium leprae PROBABLE CONSERVED LIPOPROTEIN LPQF 0.1323 0.2324 1
Brugia malayi beta-lactamase family protein 0.082 0.1338 1
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.082 0.1338 1
Trichomonas vaginalis penicillin-binding protein, putative 0.082 0.1338 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.